Sartorius Stedim Biotech acquires cell culture specialist Xell AG
AUBAGNE, France, July 29, 2021 /PRNewswire/ -- The life science company Sartorius Stedim Biotech acquired cell culture specialist XellAG headquartered in Bielefeld, Germany.
- AUBAGNE, France, July 29, 2021 /PRNewswire/ -- The life science company Sartorius Stedim Biotech acquired cell culture specialist XellAG headquartered in Bielefeld, Germany.
- "I would like to cordially welcome the Xell team to Sartorius Stedim Biotech and am looking forward to our collaboration in this demanding time."
- "Sartorius Stedim Biotech, with its strong sales team and complementary product portfolio, offers an excellent platform for further expansion, and we are extremely excited about our joint future development," added Stefan Northoff, CEO of Xell AG.
- Xell AG is a globally active biotech company with a strong focus on cell culture media as well as associated analytical and process services.